OCV Partners
Venture capitalLos Angeles · Pre-Seed–Late Stage · 5 people tracked
Also known as OCV MANAGEMENT, LLC
Investment thesis
OCV Partners invests in brilliant teams building disruptive technology, drawing on the partners' background as former founders who have grown businesses from early stages through IPOs. Its core focus areas are Technology (SaaS, FinTech, and PropTech), with expertise in subscription and recurring-revenue software models, and Healthcare (Healthcare SaaS, Digital Health, MedTech, and BioTech). In healthcare, the firm backs companies enabling precision and targeted approaches, empowering better treatment decisions, removing barriers to equitable care, and expediting discovery of new treatments. OCV aims to create asymmetric advantages for founders and offers flexible capital, preferring but not requiring to lead rounds.
Source: firm website, verified Aug 25, 2026.
Team · 5 people
from the firm's website & public directories
What they invest in
from 16 of 20 portfolio companiesHealthtech ×7Biotech ×6AI & Machine Learning ×5Consumer ×3Deep Tech ×3Medical Devices ×3Creator Economy ×2Cybersecurity ×2
HQs:United States×12
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×42 founders×43 founders×14+ founders×1
Investments · 20 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 12021 · 12018 · 15 dated
Therapeutic company focused on validated targets for treating neurological and psychiatric disorders.
BiotechCambridge, US
Kiran Reddy(Executive Officer, Director)
BoardNicholas G. Galakatos(Director)
Co-investorsClarusVida Ventures
Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
BiotechDeep TechHealthtechDurham, US
JEFF SMITH(Executive Officer)DEREK JANTZ(Executive Officer, Director)MATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)Derek Jantz(Co-founder)TODD MELBY(Executive Officer)
Co-investorsage1Aliment CapitalBrace PharmaF-Prime CapitalOUP (Osage University Partners)Pontifax AgTech+4 more
SafeBreach offers a continuous threat exposure management (CTEM) platform that combines breach and attack simulation, attack path validation, and an AI agent to help enterprise security teams identify, prioritize, and remediate cyber risk.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaS
Guy Bejerano(CEO & Co-founder)inItzik Kotler(CTO & Co-founder)inMichal Weiner(Chief Financial Officer)inRaman Kumar(Chief Customer Officer)
Co-investorsBain CapitalDTCP33NBright Pixel CapitalDnx VenturesEmerald Development Managers+2 more
ByHeart is an infant formula company navigating an FDA return-to-market process following a product outbreak investigation.
ConsumerDirect to ConsumerFoodTechHealthtechNew York, US
Mia B. Funt(Executive Officer, Director)Ron Belldegrun(Executive Officer, Director, Promoter)Mia Funt(Founder)inGeorg Krause-Vilmar(Executive Officer)Niall Mullane(Executive Officer)
BoardAmy Schulman(Director)in
Board seatHemi Zucker· per SEC Form D
Co-investorsEvolution VC PartnersPolaris PartnersRed Sea VenturesVida Ventures
HealthtechNew York, US
Ron Belldegrun(Executive Officer, Director)Georg Krause-Vilmar(Executive Officer)Mia B. Funt(Executive Officer, Director)Devon Kuehn(Executive Officer)Niall Mullane(Executive Officer)Neil Betteridge(Executive Officer)
Board seatHemi Zucker· per SEC Form D · $20.3M raise · filed Jul 2026
Co-investorsVida Ventures
Develops novel oncology therapeutics using breakthrough medicinal chemistry technology and biomarker-driven assays to accelerate drug discovery and clinical approval timelines.
Culver City, US
Brian Stoltz(Director)Mark Attanasio(Director)David Chang(Director)David Licata(Director)Dennis Slamon(Director)
Co-investorsKairos Venture Investments, Llc
Museum of Ice Cream operates interactive, ice cream-themed attractions featuring immersive rooms, a sprinkle pool, novelty desserts, cocktails, and retail products.
ConsumerMedia & Entertainment
Co-investorsElizabeth Street VenturesMaywic Select Investments
Figure 8 is an experience-first company that designs and builds immersive physical spaces ("experiums") intended to bring people together and connect them with themselves, each other, and their surroundings.
ConsumerMedia & Entertainment
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)Matt Blischak(Chief Executive Officer)R. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsB3 HoldingOctave Ventures LlcOMX VenturesShumway CapitalHumboldt
Subscription-based mobile app helping small business owners win jobs, track payments, and manage client payment options.
Co-investorsAccelRibbit Capital
Data-driven legal technology platform providing an end-to-end solution combining technology, funding, and expertise to efficiently resolve civil cases.
Ockam is an open-source library that enables developers to build secure communication channels with end-to-end encryption and mutual authentication across any network, cloud, or on-premises infrastructure.
CybersecurityDeveloper ToolsSan Francisco, US
Matthew Gregory(Founder)
Co-investorsAspect VenturesCore Ventures GroupSGH CapitalSINEWAVE VENTURESFuture Ventures
Social Native (at olapic.com) offers an AI-powered creator marketing platform trained on 1.8M+ creator collaborations and $8B in paid media, predicting brief, creator, and platform performance before spend.
AI & Machine LearningCreator EconomyE-commerceMarketing TechSocialNew York, US
David Shadpour(Founder & CEO)Eytan Elbaz(Co-Founder)inJose De Cabo(Executive Officer, Director)Ben Lin(Director)Luis Sanz Arilla(Executive Officer, Director)
Co-investorsAct One VenturesContour Venture PartnersFELIX CAPITALScout VenturesScout VenturesLongworth Venture Partners+2 more
Orca AI applies computer vision and deep learning to maritime shipping, providing situational awareness and automation tools to help commercial vessels navigate more safely and operate more efficiently.
AI & Machine LearningDeep TechLogistics & Supply ChainMobility & Transportation
Yarden Gross(Co-founder & CEO)inDor Raviv(Co-founder & CTO)inShoval Bolotin(VP Product / Operations)inFabrizio Ferraro(Global Sales Lead)inLirit(CFO)inAmit(VP R&D)in
Co-investorsAnkona CapitalBrighton Park CapitalMizMaa VenturestheDOCKSanta Barbara Venture Partners
OSSIO develops OSSIOfiber, a bio-integrative bone fixation implant material made from natural mineral fibers that provides stability during healing and integrates fully into bone over 18-24 months, avoiding permanent metal hardware.
BiotechHealthtechMedical DevicesNew MaterialsPalmetto, US
Orahn Preiss-Bloom(Founder & Chief Innovation Officer)Brian Verrier(Chief Executive Officer)Brennan Marilla(Chief Commercial and Operating Officer)Moshe Shneor(Chief Financial Officer)Gregory C. Berlet(Chief Medical Officer)
Co-investorsQuesta CapitalSecocha Ventures
Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.
BiotechDeep TechHealthtech
Co-investorsAvoro Capital AdvisorsCapria VenturesAlameda ResearchNorwest Venture Partners
Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSan Francisco, US
Dr. Jeff Chang(Co-founder)inDoktor Gurson(Co-founder)in
BoardStuart Peterson(Director)inBruce Armstrong(Director)in
PartnerChris Bostick· led
Co-investorsAlpha PartnersArray Ventures Management LlcArtis VenturesCity LightCorewell Health VenturesFifty Years+9 more
Social Native runs an AI-powered creator marketing platform that matches brands with content creators, predicts campaign performance, and manages briefs-to-payout, drawing on data from 1.8M+ creator collaborations and $8B in paid media.
AI & Machine LearningCreator EconomyMarketing Tech
David Shadpour(Founder)in
Co-investorsMiramar Venture PartnersTenOneTen Ventures
Online subscription fashion retailer carrying shoes, handbags, jewelry, and denim through brands including Fabletics, Justfab, ShoeDazzle, and Savage x Fenty.
Co-investorsCrosscut VenturesManhattan WestL CattertonNeuberger BermanSugar Capital
Clinical-stage biotechnology company developing novel antibody-based therapies to transform cancer treatment.
BiotechCulver City, US
Mark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)Amit Sinha(Director)Lynn Seely(Director)
PartnerChris Bostick· led
Co-investorsCowen Healthcare InvestmentsGoldman SachsPerceptive Xontogeny VentureVertex Ventures HC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
IPOs and acquisitions across the tracked portfolioPraxis Precision MedicinesNASDAQ: PRAXPrecision BioSciencesNASDAQ: DTIL
Portfolio news
latest coverage across their companiesPraxis Precision Medicines · investing.com · Aug 17, 2026
Precision BioSciences · tradingkey.com · Aug 6, 2026
MeridianMade, Inc. · alleywatch.com · Jul 27, 2026
OSSIO · finance.yahoo.com · Jul 6, 2026
TechStyle Fashion Group · altss.com · Jun 3, 2026
Olapic · trysignalbase.com · Mar 24, 2026
TORL BioTherapeutics · endpoints.news · Oct 7, 2025
Rad AI · finsmes.com · May 20, 2025
Frequently asked questions
- How many investments has OCV Partners made?
- OCV Partners has 19 tracked investments, including 1 dated in the last 24 months.
- What stage does OCV Partners invest at?
- OCV Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does OCV Partners focus on?
- OCV Partners focuses on AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, PropTech, SaaS.
- Where is OCV Partners located?
- OCV Partners is headquartered in Los Angeles, US.
- Does OCV Partners lead rounds?
- Yes, OCV Partners leads investment rounds.
- Who does OCV Partners co-invest with?
- OCV Partners most often shares deals with Artis Ventures, Aspect Ventures, Crosscut Ventures, among 56 tracked co-investors.
From the blog
visit blog ↗Recent posts cover portfolio company developments in healthcare and maritime AI, including Rad AI's radiology generative AI products, its $60M Series C raise and RSNA Ventures partnership, and Orca AI's $72.5M raise for autonomous ship navigation. AI summary
Media · Podcasts & interviews
featuring the teamChris Bostick, OCV Partners
socaltech · Chris Bostick
Images
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
AddVentures is the corporate venture capital arm of SCG, one of the largest industrial conglomerates in Southeast Asia. It engages with tech startups worldwide through partnerships and investments, leveraging SCG's network and resources across the region.
Angel Bridge is a Japanese venture capital firm that emphasizes hands-on support as a 'supporter of entrepreneurs,' aiming to help create world-class mega ventures.